
Opinion|Videos|November 22, 2024
Final Thoughts
Key Takeaways
The panel discussion concludes with final thoughts on the future landscape of newly diagnosed multiple myeloma.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
November 2025 Pharmacy Policy Updates
3
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
4
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
5















































































































































































































